# ALL-SCT BFM International- HSCT in Children and Adolescents With ALL

Source: https://onco.cc/trials/nct01423500/  
OnCo record `nct01423500` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Fludarabine, Treosulfan and Thiotepa in Leukaemia, run by St. Anna Kinderkrebsforschung, with a status the registry has not verified recently.

## Summary

ALL-SCT BFM International- HSCT in Children and Adolescents With ALL is a phase 3 interventional study registered as NCT01423500 by St. Anna Kinderkrebsforschung, with 405 participants planned, started 2007-01 and due to reach its primary completion in 2011-09. Interventions recorded: VP16, TBI, VP16, ATG, TBI, Fludarabine, OKT3, Treosulfan, Thiotepa, VP16, ATG, TBI. Conditions recorded: Lymphoblastic Leukemia, Acute, Childhood;.

Linked to the drug Treosulfan because the registry names it among its interventions and Leukaemia among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT01423500
- Phase: 3
- Setting: Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia
- Sponsor: St. Anna Kinderkrebsforschung
- Enrolled: 405

## Sources

- ClinicalTrials.gov NCT01423500: https://clinicaltrials.gov/study/NCT01423500

## Connected records

- cancers: [Leukaemia (all types)](https://onco.cc/cancers/leukaemia/)
- drugs: [Fludarabine](https://onco.cc/drugs/fludarabine/), [Thiotepa](https://onco.cc/drugs/thiotepa/), [Treosulfan](https://onco.cc/drugs/treosulfan/)

---
JSON: https://onco.cc/api/v1/entities/nct01423500.json